Mobile Platform for Optimizing Wellness and Engagement in Recovery

University of Michigan50 enrolled

Overview

This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Opioid Agonist Treatment Alcohol Use Disorder Opioid Use Disorder

Interventions

Digital Contingency Management Intervention ArmBEHAVIORAL

Participants will use a version of the app for 6-months. Participants in this group may earn rewards for completing recovery-related activities and for abstinence from drugs and alcohol. During the 6 months this will include: random saliva drug tests, breathalyzer tests, and video selfies, completing surveys and questionnaires through the app, and receiving rewards on a debit card for abstinent tests, surveys, and activities. Additionally, participants will complete follow-up at approximately 9 months after randomization.

Digital Wellness ArmBEHAVIORAL

Participants will use a version of the app for 6-months focussed on wellness. During the 6 months this will include: random requests to do saliva drug tests, breathalyzer tests, and video selfies, complete surveys and questionnaires through the app, and receive rewards on a debit card for completing tests, surveys, and activities. Participants in this group may also earn rewards for completing study activities like tests and surveys. Additionally, participants will complete follow-up at approximately 9 months after randomization.

Eligibility

Sex: ALLMin age: 19 YearsMax age: 63 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Participants must be enrolled in the Michigan Medicaid program * Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone * Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening * Participants must have regular access to a working smartphone and internet connection. * Participants must have a reliable mailing address to receive study supplies (e.g., salivary drug tests). Exclusion Criteria: * Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid claims data for this group * Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency * Individuals with substantial cognitive impairment that would interfere with study participation * Individuals unable to read or understand English * Individuals experiencing active suicidality or psychosis. * Individuals with a planned admission to residential treatment or incarceration during the study period.

Locations (1)

University of Michigan

Ann Arbor, Michigan, United States

RECRUITING

Outcomes

Primary Outcomes

Feasibility based on recruitment

Recruitment: ≥60% of participants enrolled

Time frame: Recruitment period 12 months

Feasibility based on adherence

Adherence: ≥50% of app-based, biochemically-verified tests completed in the digital CM condition.

Time frame: 6 months (during the Dynamicare program)

Feasibility based on Retention

Retention: ≥70% of participants retained at 6 months

Time frame: 6 months

Acceptability of the intervention

Defined as \>70% of participants rating the intervention experience ≥ 4/5 on the Acceptability of Intervention Measure

Time frame: 3-month after starting program

Central Contacts

Haley Stevens

CONTACT

734-764-9910 hsteve@med.umich.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.